Literature DB >> 8927012

Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995.

.   

Abstract

Before effective vaccines were available, Haemophilus influenzae type b (Hib) was the most common cause of bacterial meningitis among children in the United States, and an estimated one of 200 children aged < 5 years developed invasive Hib disease. From December 1987--when Hib conjugate vaccines were introduced--through 1994, the incidence of invasive Hib disease declined 95% among children aged < 5 years. Eliminating invasive Hib disease among children aged < 5 years by 1996 is a goal of the Childhood Immunization Initiative (CII). This report summarizes data about trends in invasive H. influenzae (Hi) disease during 1987-1995 from three separate surveillance systems (CDC's National Notifiable Diseases Surveillance System [NNDSS]; the National Bacterial Meningitis and Bacteremia Reporting System [NBMBRS]; and an active, multistate, laboratory-based surveillance system). The findings underscore the need for age-appropriate vaccination of infants and for complete investigation and reporting of cases of invasive Hi disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8927012

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  20 in total

1.  Measurement of serum bactericidal activity specific for Haemophilus influenzae type b by using a chromogenic and fluorescent metabolic indicator.

Authors:  Sandra Romero-Steiner; Willie Spear; Nekeidra Brown; Patricia Holder; Thomas Hennessy; Patricia Gomez De Leon; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

2.  Haemophilus influenzae type b carriage among young children in metropolitan Atlanta in the context of vaccine shortage and booster dose deferral.

Authors:  Jennifer Dolan Thomas; Michael L Jackson; Dolly Sharma; Raydel Mair; Michelle C Bach; Dana Castillo; O Grace Ejigiri; Sarah Satola; Amanda C Cohn; Robert Jerris; Shabnam Jain; Monica M Farley; Leonard W Mayer; Nancy E Messonnier
Journal:  Clin Vaccine Immunol       Date:  2011-10-19

3.  Developing the right pneumococcal vaccine for the time and place.

Authors:  Sanjay Mehta
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

4.  Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.

Authors:  Mandeep S Dhingra; Raman Rao; Swarnarekha Bhat; Rajan Joshi; Veena Kalra; Harish R Parikh; S Narasimha Rao; G R Sethi; Nitin Shah; M Muzaffaruddin
Journal:  Hum Vaccin       Date:  2010-07

Review 5.  Vaccine-induced pathogen strain replacement: what are the mechanisms?

Authors:  Maia Martcheva; Benjamin M Bolker; Robert D Holt
Journal:  J R Soc Interface       Date:  2008-01-06       Impact factor: 4.118

Review 6.  Management of the non-toxic-appearing acutely febrile child: a 21st century approach.

Authors:  Ravi Jhaveri; Carrie L Byington; Jerome O Klein; Eugene D Shapiro
Journal:  J Pediatr       Date:  2011-05-17       Impact factor: 4.406

7.  Functional antibody activity elicited by fractional doses of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate).

Authors:  S Romero-Steiner; J Fernandez; C Biltoft; M E Wohl; J Sanchez; J Feris; S Balter; O S Levine; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

8.  Avidity determinations for Haemophilus influenzae Type b anti-polyribosylribitol phosphate antibodies.

Authors:  Sandra Romero-Steiner; Patricia F Holder; Patricia Gomez de Leon; Willie Spear; Thomas W Hennessy; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

9.  Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.

Authors:  Heidi M Soeters; Amy Blain; Tracy Pondo; Brooke Doman; Monica M Farley; Lee H Harrison; Ruth Lynfield; Lisa Miller; Susan Petit; Arthur Reingold; William Schaffner; Ann Thomas; Shelley M Zansky; Xin Wang; Elizabeth C Briere
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

10.  Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease.

Authors:  K M Bisgard; A Kao; J Leake; P M Strebel; B A Perkins; M Wharton
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.